Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Aug 31, 2024 | (FY)Aug 31, 2023 | (FY)Aug 31, 2022 | (FY)Aug 31, 2021 | (FY)Aug 31, 2020 | (FY)Aug 31, 2019 | (FY)Aug 31, 2018 | (FY)Aug 31, 2017 | (FY)Aug 31, 2016 | (FY)Aug 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 38.51%569.89M | -51.91%411.45M | -39.10%855.57M | 1,419.01%1.4B | -70.15%92.49M | -28.92%309.83M | 233.11%435.88M | -151.98%-327.45M | 353.41%629.89M | -2,320.79%-248.57M |
Net profit before non-cash adjustment | 58.04%214.42M | -66.09%135.67M | 86.63%400.04M | 119.12%214.35M | -2,173.68%-1.12B | 22.83%54.07M | -84.77%44.02M | 142.95%289.08M | 11.69%118.99M | -23.85%106.54M |
Total adjustment of non-cash items | -7.30%291.28M | -1.11%314.23M | 5.87%317.77M | -61.59%300.15M | 78.68%781.39M | 35.11%437.32M | 24.10%323.68M | -32.57%260.82M | 82.52%386.81M | -0.21%211.93M |
-Depreciation and amortization | -6.22%189.08M | -4.55%201.62M | -6.01%211.23M | -32.40%224.73M | -1.98%332.44M | 20.12%339.16M | 40.98%282.35M | 6.21%200.28M | 10.95%188.58M | 31.00%169.97M |
-Reversal of impairment losses recognized in profit and loss | -64.24%7.42M | -11.11%20.76M | 107.89%23.36M | -96.20%11.24M | 1,664.00%295.65M | --16.76M | ---- | 20.56%21.59M | 167.18%17.91M | --6.7M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 385.32%39.5M | -152.90%-13.84M |
-Disposal profit | 171.09%4.47M | --1.65M | --0 | -89.18%8.79M | 482.94%81.27M | 252.88%13.94M | -810.08%-9.12M | -105.61%-1M | --17.86M | --0 |
-Net exchange gains and losses | -800.69%-6.11M | -75.65%872K | 388.33%3.58M | 83.29%-1.24M | -1,220.81%-7.43M | 191.45%663K | 91.59%-725K | -137.35%-8.62M | 215.78%23.08M | -758.77%-19.93M |
-Remuneration paid in stock | 169.33%3.03M | -62.51%1.13M | --3M | ---- | -26.16%5.1M | 24.41%6.91M | 3.48%5.56M | 13.15%5.37M | -0.52%4.75M | 2.47%4.77M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 190.85%47.18M | 332.82%16.22M |
-Other non-cash items | 5.88%93.39M | 15.15%88.2M | 35.24%76.6M | -23.83%56.64M | 24.17%74.36M | 31.29%59.89M | 5.60%45.62M | -9.92%43.2M | -0.18%47.96M | 19.11%48.04M |
Changes in working capital | 266.94%64.19M | -127.91%-38.45M | -84.53%137.77M | 105.98%890.4M | 338.09%432.28M | -366.30%-181.56M | 107.77%68.18M | -806.98%-877.35M | 121.89%124.1M | -56.41%-567.04M |
-Change in receivables | -3,014.86%-182.24M | 110.28%6.25M | -149.45%-60.83M | -47.49%123.01M | 425.02%234.29M | 6.94%-72.08M | 58.89%-77.46M | -469.95%-188.43M | 165.61%50.94M | 21.22%-77.63M |
-Change in inventory | -242.87%-211.14M | -18.43%147.79M | -65.16%181.18M | 8.73%519.98M | 999.88%478.22M | 64.90%-53.14M | 72.02%-151.38M | -588.15%-541.09M | 82.80%-78.63M | -135.22%-457.12M |
-Change in payables | 205.91%144.89M | -204.10%-136.8M | -18.53%131.42M | 149.49%161.31M | -84.85%-325.92M | -207.30%-176.31M | 2,850.91%164.31M | -124.92%-5.97M | -84.78%23.97M | 175.37%157.51M |
-Provision for loans, leases and other losses | 262.00%68.49M | -139.22%-42.28M | -123.02%-17.67M | -9.47%76.77M | 36,454.31%84.81M | -97.73%232K | 171.63%10.2M | ---14.24M | ---- | ---- |
-Changes in other current assets | 96.61%53.25M | 472.51%27.09M | -357.11%-7.27M | 169.43%2.83M | 90.09%-4.07M | -162.62%-41.09M | 211.20%65.62M | -146.17%-59.01M | 167.35%127.83M | -236.22%-189.8M |
-Changes in other current liabilities | 571.48%190.94M | 54.53%-40.5M | -1,471.36%-89.06M | 118.53%6.49M | -121.79%-35.05M | 182.73%160.84M | 182.92%56.89M | ---68.6M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -9.66%-85.53M | 3.70%-77.99M | -60.91%-80.99M | 2.56%-50.33M | -10.05%-51.65M | -23.54%-46.93M | 2.38%-37.99M | 5.00%-38.92M | 8.54%-40.97M | -10.73%-44.79M |
Interest received (cash flow from operating activities) | 54.59%3.54M | 38.16%2.29M | -31.54%1.66M | 49.04%2.42M | -21.97%1.62M | 109.26%2.08M | 73.47%994K | -29.61%573K | -37.91%814K | 4.38%1.31M |
Tax refund paid | 113.42%9.88M | -20.78%-73.63M | -424.21%-60.97M | -68.55%-11.63M | 91.88%-6.9M | 29.98%-84.93M | 19.06%-121.3M | -405.91%-149.87M | 80.25%-29.62M | -141.14%-149.95M |
Other operating cash inflow (outflow) | 34.52%-10.58M | -112.71%-16.16M | 5.37%-7.6M | 64.64%-8.03M | -140.07%-22.7M | -41.11%-9.46M | -28.77%-6.7M | 0.10%-5.2M | -0.06%-5.21M | -520,700.00%-5.21M |
Operating cash flow | 98.08%487.2M | -65.24%245.96M | -47.08%707.68M | 10,299.20%1.34B | -92.46%12.86M | -37.02%170.59M | 152.01%270.88M | -193.86%-520.86M | 224.08%554.91M | -300.55%-447.21M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 16.81%-140.62M | -15.95%-169.03M | -4.84%-145.78M | 17.37%-139.04M | 16.22%-168.27M | 17.46%-200.85M | -99.37%-243.34M | 21.77%-122.06M | 11.55%-156.02M | -116.25%-176.39M |
Net intangibles purchase and sale | 66.00%-22.7M | -193.18%-66.77M | -197.09%-22.78M | 74.37%-7.67M | -121.85%-29.91M | -9.58%-13.48M | 87.47%-12.3M | -587.31%-98.22M | -614.50%-14.29M | 68.98%-2M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --108.21M | ---- | ---- |
Net investment product transactions | ---- | ---- | ---- | ---- | ---- | --30M | ---- | ---- | ---- | ---- |
Net changes in other investments | 50.37%-14.38M | -321.77%-28.98M | -90.63%13.07M | 677.85%139.49M | 125.88%17.93M | -22.23%-69.3M | 53.72%-56.7M | -371.94%-122.5M | 59.46%-25.96M | -124.99%-64.03M |
Investing cash flow | 32.89%-177.7M | -70.29%-264.78M | -2,054.14%-155.49M | 96.00%-7.22M | 28.94%-180.24M | 18.80%-253.63M | -33.16%-312.34M | -19.52%-234.56M | 19.04%-196.26M | -108.13%-242.43M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -180.65%-39.94M | 110.63%49.52M | 58.90%-465.98M | -296.63%-1.13B | 94.87%576.6M | 110.87%295.89M | -74.97%140.32M | 997.78%560.51M | -108.75%-62.43M | 250.86%713.92M |
Net common stock issuance | -47.52%920K | -38.08%1.75M | 46.76%2.83M | 109.95%1.93M | -1,498.34%-19.38M | -97.23%1.39M | -8.72%49.98M | 14,032.57%54.76M | 2.48%-393K | -467.61%-403K |
Increase or decrease of lease financing | 41.80%-26.84M | 52.15%-46.12M | 6.58%-96.38M | 11.45%-103.17M | 5.42%-116.52M | -11.61%-123.19M | -72.44%-110.38M | -31.70%-64.01M | -16.31%-48.6M | -36.88%-41.79M |
Cash dividends paid | -0.54%-23.51M | 1.54%-23.39M | -263,800.00%-23.75M | 99.96%-9K | -0.40%-23.44M | -2.09%-23.34M | -1.96%-22.87M | 0.08%-22.43M | 0.25%-22.45M | -0.46%-22.5M |
Net other fund-raising expenses | ---- | ---- | ---- | 0.00%-2K | 0.00%-2K | -100.00%-2K | -100.01%-1K | --7.99M | ---- | 33.33%-2K |
Financing cash flow | -389.95%-89.37M | 96.87%-18.24M | 52.77%-583.28M | -395.99%-1.24B | 176.82%417.26M | 164.20%150.73M | -89.37%57.05M | 501.00%536.83M | -120.62%-133.87M | 331.45%649.22M |
Net cash flow | ||||||||||
Beginning cash position | -1.87%966.46M | -5.30%984.86M | 9.41%1.04B | 36.04%950.57M | 9.74%698.72M | 2.04%636.71M | -24.34%623.99M | 31.84%824.77M | -4.37%625.61M | -10.25%654.21M |
Current changes in cash | 694.07%220.13M | -19.19%-37.06M | -132.70%-31.09M | -61.95%95.08M | 269.13%249.88M | 334.24%67.69M | 107.13%15.59M | -197.25%-218.6M | 656.17%224.77M | 47.96%-40.41M |
Effect of exchange rate changes | -66.63%6.23M | 177.53%18.66M | -327.30%-24.06M | -386.27%-5.63M | 134.59%1.97M | -98.22%-5.69M | -116.11%-2.87M | 169.57%17.81M | -316.78%-25.61M | 296.91%11.81M |
Cash adjustments other than cash changes | ---- | ---- | ---- | ---1K | ---- | --1K | ---- | --1K | ---- | ---- |
End cash Position | 23.42%1.19B | -1.87%966.46M | -5.30%984.86M | 9.41%1.04B | 36.04%950.57M | 9.74%698.72M | 2.04%636.71M | -24.34%623.99M | 31.84%824.77M | -4.37%625.61M |
Free cash flow | 3,087.21%323.88M | -98.12%10.16M | -54.72%539.12M | 742.51%1.19B | -323.65%-185.31M | -387.17%-43.74M | 102.03%15.23M | -294.66%-748.66M | 161.48%384.6M | -213.32%-625.6M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |